| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2013 | WO2013014325A1 Uses of membrane vesicles of a marine organism for the industrial use thereof and method for obtaining same |
| 01/31/2013 | WO2013014312A1 Chimeric polypeptides derived from the vimentin protein, suitable for use in the diagnosis of rheumatoid arthritis |
| 01/31/2013 | WO2013014293A1 Anitmicrobial peptide produced by intestinal lactobacillus salivarius |
| 01/31/2013 | WO2013014261A1 Prevention of salmonella recrudescense |
| 01/31/2013 | WO2013014134A2 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
| 01/31/2013 | WO2013014105A1 Prame purification |
| 01/31/2013 | WO2013013639A1 Tnf-related apoptosis-inducing ligand fusion protein and preparation and use thereof |
| 01/31/2013 | WO2013013626A1 Deletion mutant of recombinant human nerve growth factor, preparation method and use thereof |
| 01/31/2013 | WO2013013602A1 Method for preparing and renaturing chicken interferon γ |
| 01/31/2013 | WO2012168431A3 Polypeptides |
| 01/31/2013 | WO2012168430A3 Polypeptides |
| 01/31/2013 | WO2012164413A3 Wdr13 as a novel biomarker useful for treating diabetes and cancer |
| 01/31/2013 | WO2012140627A4 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer |
| 01/31/2013 | WO2012122125A3 Compositions and methods targeting force generation in kinesin |
| 01/31/2013 | WO2012110878A3 Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity |
| 01/31/2013 | US20130031670 Plants having enhanced yield-related traits and method for making the same |
| 01/31/2013 | US20130031667 Anti-nematode peptides and methods of use thereof |
| 01/31/2013 | US20130030526 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130030161 Procedure for obtaining a composition containing growth factors from a blood compound, and composition obtained by said procedure |
| 01/31/2013 | US20130030153 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130030152 Target and method for inhibition of bacterial rna polymerase |
| 01/31/2013 | US20130030039 Novel multidrug resistance-associated polypeptide |
| 01/31/2013 | US20130029914 Sebum secretion-blocking composition, and food or beverage containing same |
| 01/31/2013 | US20130029913 Artificial platelets |
| 01/31/2013 | US20130029911 Albumin fusion proteins |
| 01/31/2013 | US20130029903 Azuvirin Peptides |
| 01/31/2013 | US20130029865 Stromal Antigen 2 (STAG2) Compositions and Methods |
| 01/31/2013 | US20130029844 Cyclotides Having Nematocidal Activity and Methods of Use Thereof |
| 01/31/2013 | US20130029400 Genetic elements, proteins, and associated methods including application of addiitnal genetic information to gram (+) thermoacidophiles |
| 01/31/2013 | US20130029399 Metal salen complex derivative and process for production thereof |
| 01/31/2013 | US20130029396 Multifunctional Biomemory Device |
| 01/31/2013 | US20130029367 Compositions and methods for monitoring breast cancer treatment |
| 01/31/2013 | US20130029360 Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same |
| 01/31/2013 | US20130029358 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| 01/31/2013 | US20130029330 Mutant ldl receptor gene |
| 01/31/2013 | US20130029327 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 01/31/2013 | US20130029325 Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe |
| 01/31/2013 | US20130028939 Chimeric human beta defensins |
| 01/31/2013 | US20130028933 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 01/31/2013 | US20130028926 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 01/31/2013 | US20130028923 Kdr peptides and vaccines comprising the same |
| 01/31/2013 | US20130028922 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/31/2013 | US20130028914 Antibodies that Bind Tau Oligomers |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | US20130028867 Long-acting interferon beta formulation using immunoglobulin fragment |
| 01/31/2013 | US20130028836 Chlorotoxin polypeptides and conjugates and uses thereof |
| 01/31/2013 | CA2844357A1 Axmi270 toxin gene and methods for its use |
| 01/31/2013 | CA2842543A1 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
| 01/31/2013 | CA2842530A1 Axmi205 variant proteins and methods for their use |
| 01/31/2013 | CA2841541A1 Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene |
| 01/31/2013 | CA2841380A1 Prame purification |
| 01/30/2013 | EP2551345A1 Hcv variant with high productivity of infectious hepatitis c virus, and use thereof |
| 01/30/2013 | EP2551342A2 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells |
| 01/30/2013 | EP2551282A2 Antibodies against CD38 for treatment of multiple myeloma |
| 01/30/2013 | EP2551281A1 Splice variants of GDNF and uses thereof |
| 01/30/2013 | EP2551280A2 Contraceptive peptides derived from spider venom |
| 01/30/2013 | EP2551279A1 Antimicrobial peptide produced by intestinal Lactobacillus salivarius |
| 01/30/2013 | EP2550958A1 Controlled release formulations of lipocalin muteins |
| 01/30/2013 | EP2550359A1 Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof |
| 01/30/2013 | EP2550356A2 Method of altering the differentiative state of a cell and compositions thereof |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550293A1 Bacillus pumilus bilirubin oxidase and applications thereof |
| 01/30/2013 | EP2550292A2 Flavivirus host range mutations and uses thereof |
| 01/30/2013 | EP2550291A1 Salt-resistant emulsions |
| 01/30/2013 | EP2550290A2 Method of modifying a specific lysine |
| 01/30/2013 | EP2550289A2 Novel immunogens and methods for discovery and screening thereof |
| 01/30/2013 | EP2550013A1 Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 01/30/2013 | EP2550009A1 Dendritic cell inhibitory proteins from ticks |
| 01/30/2013 | EP2549859A1 Primate model from the family cercopithecidae infected by a hbv strain of human genotype |
| 01/30/2013 | CN1977166B Detection of methamphetamine class of drugs |
| 01/30/2013 | CN1835968B Compositions and methods for increasing bone mineralization |
| 01/30/2013 | CN102906267A Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
| 01/30/2013 | CN102906266A Universal dengue virus sequences and methods of use |
| 01/30/2013 | CN102906245A Hyperblebbing shigella strains |
| 01/30/2013 | CN102906120A Recombinant human G-CSF dimer and use thereof for treatment of neurological diseases |
| 01/30/2013 | CN102906110A Antimicrobial agents based on hemin derivatives |
| 01/30/2013 | CN102906109A Chemically modified water-soluble elastin, mixed gels of chemically modified water-soluble elastin with collagen and method for producing same |
| 01/30/2013 | CN102906108A Method for producing soluble recombinant interferon protein without denaturing |
| 01/30/2013 | CN102906107A High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein |
| 01/30/2013 | CN102906106A Genetically modified bacterium of species listeria monocytogenes |
| 01/30/2013 | CN102905725A Marker vaccine for classical swine fever |
| 01/30/2013 | CN102905722A Long-acting Y2 receptor agonists |
| 01/30/2013 | CN102905555A Rehydratable food |
| 01/30/2013 | CN102899335A Method for obtaining genome sequence of papaya ringspot virus through high-throughput small RNA sequencing |
| 01/30/2013 | CN102899334A Mycobacterium tuberculosis recombinant protein and preparation method thereof |
| 01/30/2013 | CN102899333A Rice salt stress related gene SIDP364 and coding protein and application thereof |
| 01/30/2013 | CN102899332A Rice salt coercion related gene SIDP361 and encoding protein and application thereof |
| 01/30/2013 | CN102899331A Complex duck interferon-alpha gene, and recombinant vector and application thereof |
| 01/30/2013 | CN102899330A Transforming growth factor-beta (TGF-beta) type I receptor gene of chlamys farreri and single nucleotide polymorphism (SNP) locus of TGF-beta type I receptor gene |
| 01/30/2013 | CN102899329A Construction method for more stable mutant of humanized proteasome activity factor |
| 01/30/2013 | CN102898526A Tumor necrosis factor-related apoptosis-inducing ligand fusion protein, its preparation and application |
| 01/30/2013 | CN102898516A Method for purifying lactoferrin from milk serum by using an expanded bed adsorption technology |
| 01/30/2013 | CN102898515A Polybrominated biphenyls homologue immunogen and preparation method |
| 01/30/2013 | CN102898514A Recombinant human nerve growth factor deletion mutant, its preparation method and application |
| 01/30/2013 | CN102898513A ELISpot optical neuromyelitis diagnostic kit and application thereof |
| 01/30/2013 | CN102898512A Recombinant plectasin as well as preparation method and application of recombinant plectasin |
| 01/30/2013 | CN102898511A Purification method in preparation of methicillin staphylococcus aureus-resistant recombinant genetic engineering vaccine candidate antigen I12C |
| 01/30/2013 | CN102898486A Comprehensive method for preparation of raffinose and gossypol from cottonseed meal |
| 01/30/2013 | CN102898410A Method for preparing anti-coagulation raticide bromadiolone half antigen and complete antigen |